Finance

Lists
08HH:FRA
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
2,03 €
-1,60%
(-0,033) 1D
2 ოქტ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 08HH...
Open
2,03 €
High
2,03 €
Low
2,03 €
Mkt. cap
68,17 მლრდ.
Avg. vol.
917,00
Volume
0,00
52-wk high
2,87 €
52-wk low
1,66 €
No. of employees
41 ათ.
Open
2,03 €
High
2,03 €
Low
2,03 €
Mkt. cap
68,17 მლრდ.
Avg. vol.
917,00
Volume
0,00
52-wk high
2,87 €
52-wk low
1,66 €
No. of employees
41 ათ.
News stories
From web sources and news partners
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOლიუ აი | ვენ დეიონგ
Employees40,7 ათ.
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitefosunpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
9,88 მლრდ.
12,27 მლრდ.
10,07 მლრდ.
10,37 მლრდ.
Cost of goods sold
5,08 მლრდ.
5,65 მლრდ.
5,07 მლრდ.
5,23 მლრდ.
Cost of revenue
5,08 მლრდ.
5,65 მლრდ.
5,07 მლრდ.
5,23 მლრდ.
Research and development expenses
1,01 მლრდ.
1,28 მლრდ.
896,79 მლნ.
1,19 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 მლრდ.
4,44 მლრდ.
3,27 მლრდ.
3,35 მლრდ.
Operating expense
4,04 მლრდ.
5,92 მლრდ.
4,19 მლრდ.
4,63 მლრდ.
Total operating expenses
9,12 მლრდ.
11,57 მლრდ.
9,26 მლრდ.
9,86 მლრდ.
Operating income
758,38 მლნ.
699,05 მლნ.
813,78 მლნ.
505,27 მლნ.
Other non operating income
-116,85 მლნ.
107,33 მლნ.
2,03 მლნ.
-13,28 მლნ.
EBT including unusual items
1,12 მლრდ.
1,27 მლრდ.
1,36 მლრდ.
1,23 მლრდ.
EBT excluding unusual items
1,49 მლრდ.
1,10 მლრდ.
1,21 მლრდ.
1,07 მლრდ.
Income tax expense
162,98 მლნ.
82,80 მლნ.
277,92 მლნ.
159,73 მლნ.
Effective tax rate
14,57%
6,50%
20,47%
13,00%
Other operating expenses
-92,19 მლნ.
117,57 მლნ.
19,04 მლნ.
74,01 მლნ.
Net income
821,33 მლნ.
847,27 მლნ.
870,83 მლნ.
850,64 მლნ.
Net profit margin
8,31%
6,91%
8,64%
8,20%
Earnings per share
-
-
-
-
Interest and investment income
1,05 მლრდ.
732,13 მლნ.
689,67 მლნ.
938,86 მლნ.
Interest expense
-321,25 მლნ.
-291,32 მლნ.
-296,51 მლნ.
-310,88 მლნ.
Net interest expenses
727,28 მლნ.
440,80 მლნ.
393,16 მლნ.
627,98 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,39 მლრდ.
1,47 მლრდ.
1,59 მლრდ.
1,24 მლრდ.
Gain or loss from assets sale
2,12 მლნ.
-69,35 მლნ.
-
-195,23 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები